Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: A European Association of Cardiovascular Imaging report of literature review and current practice

European Heart Journal Cardiovascular Imaging

Volumn 18, Issue 5, 2017, Pages 489-498

  Chambers, John B ^a   Garbi, Madalina ^b   Nieman, Koen ^c   Myerson, Saul ^d   Pierard, Luc A ^e   Habib, Gilbert ^f,g   Zamorano, Jose Luis ^h   Edvardsen, Thor ⁱ   Lancellotti, Patrizio ^e,j   Delgado, Victoria ^k   Cosyns, Bernard ^k   Donal, Erwan ^k   Dulgheru, Raluca ^k   Galderisi, Maurizio ^k   Lombardi, Massimo ^k   Muraru, Denisa ^k   Kauffmann, Philipp ^k   Cardim, Nuno ^k   Haugaa, Kristina ^k   Rosenhek, Raphael ^k  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f AIX MARSEILLE UNIVERSITÉ   (France)

^g TIMONE HOSPITAL   (France)

^h UNIVERSITY OF ALCALÁ   (Spain)

ⁱ OSLO UNIVERSITY HOSPITAL   (Norway)

^j Anthea Hospital   (Italy)

^k Anthea Hospital ^*

more..

Author keywords

heart valve disease; intervention; other cardiac structures assessment; risk assessment; screening; valve assessment; valve disease detection

Indexed keywords

ADULT; AORTA; CARDIAC IMAGING; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SURVEILLANCE; EUROPE; HEART LEFT VENTRICLE; HEART MURMUR; HEART RIGHT VENTRICLE; HEART VALVE; HEART VALVE SURGERY; HUMAN; INCIDENTAL FINDING; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; MALE; MEDICAL SOCIETY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; CARDIAC IMAGING TECHNIQUES; ECHOCARDIOGRAPHY; EUROPE; FEMALE; HEART VALVE DISEASES; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING, CINE; MALE; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL;

EID: 85026679700     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jew309     Document Type: Review

References (98)

1. Chambers J, Myerson S, Rajani R, Morgan-Hughes G, Dweck M on behalf of the British Heart Valve Society. Multimodality imaging in heart valve disease. OpenHeart 2016;3:e000330.
2. Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J 2014;35:624-32.
3. Zamorano J, Gonçalves A, Lancellotti P, Andersen KA, González-Gómez A, Monaghan M et al. The use of imaging in new transcatheter interventions: an EACVI review paper. Eur Heart J Cardiovasc Imaging 2016;17:835.
4. Stewart IM. Systolic murmurs in 525 healthy young adults. Br Heart J 1951; 13:561-5.
5. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
6. Lindekleiv H, Løchen M-L, Mathiesen EB, Njølstad I, Wilsgaard T, Schirmer HD. Echocardiographic screening of the general population and long-term survival. A randomized clinical study. JAMA Int Med 2013;173:1592-8.
7. d'Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J 2016; doi:10.1093/eurheartj/ehw229.
8. Lindroos M, Kupari M, Heikkala J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5.
9. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromsø Study. Heart 2013; 99:396-400.
10. Das P, Pocock C, Chambers J. The patient with a systolic murmur: severe aortic stenosis may be missed during cardiovascular examination. QJ Med 2000; 93:685-88.
11. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. J Am Soc Echocardiogr 2011;24:229-67.
12. Mishra M, Chambers JB, Jackson G. Murmurs in pregnancy: an audit of echocardiography. Br Med J 1992;304:1413-4.
13. Chambers J, Ray S, Prendergast B, Taggart D, Westaby S, Grothier L et al. Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease. Heart 2013;99:1714-6.
14. Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P et al. Heart valve clinics: organisation, structure and experiences. Eur Heart J 2013; 34:1597-606.
15. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC et al. The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Eur Heart J 2003;24:442-63.
16. Chambers J, Kabir S, Cajeat E. Detection of heart disease by open access echocardiography: a retrospective analysis of general practice referrals. Br J Gen Pract 2014;64:e105-110.
17. Gondrie MJA, van der Graaf Y, Jacobs PC, Oen AL, Mali WPTM. The association of incidentally detected heart valve calcification with future cardiovascular events. Eur J Radiol 2011;21:963-73.
18. Koos R, Kühl HP, Mühlenbruch G, Wildberger JE, Gunther RW, Mahnken AH. Prevalence and clinical importance of aortic valve calcification detected incidentally on CT scans: comparison with echocardiography. Radiology 2006;241:76-82.
19. Webb J, Thoenes M, Chambers J. Identifying heart valve disease in primary care: differences between practice in Germany, France and the United Kingdom. Eur J Cardiovasc Med 2014;LII(1). 10.5083/ejcm.20424884.124.
20. McBrien ME, Heyburn G, Stevenson M, McDonald S, Johnston NJ, Elliott JR et al. Previously undiagnosed aortic stenosis revealed by auscultation in the hip fracture population - echocardiographic findings, management and outcome. Anaesthesia 2009;64:863-70.
21. Loxdale SJ, Sneyd JR, Donovan A, Werrett G, Viira DJ. The role of routine preoperative bedside echocardiography in detecting aortic stenosis in patients with a hip fracture. Anaesthesia 2012;67:51-4.
22. Arden C, Chambers J, Ray S, Prendergast B, Taggart D, Westaby S et al. Can we improve the detection of heart valve disease? Heart 2014;100:271-3.
23. McBride KL, Garg V. Heredity of bicuspid aortic valve: is family screening indicated? Heart 2011;97:1193-5.
24. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al. 2008 guidelines for the management of adults with congenital heart disease. JACC 2008;52:e143-263.
25. Zuily S, Regnault V, Seton-Suty C, Eschwege V, Bruntz J-F, Bode-Dotto E et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Meta-analysis of echocardiographic studies. Circulation 2011;124:215-24.
26. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 2004;351:1227-38.
27. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357:439-41.
28. Marijon E, Ou P, Celermajer S, Ferreira B, Mocumbi AO, Jani D et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-6.
29. Dahl CF, Allen MR, Urie PM, Hopkins PN. Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med 2008;6:34.
30. Antonini A, Poewe W. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson disease. Lancet Neurol 2007;6:826-9.
31. Le Ven F, Tribouilloy C, Habib G, Gueffet J-P, Maréchaux S, Eicher J-C et al. Valvular disease associated with benfluorex therapy: results from the French multicentre registry. Eur J Echo 2011; 12:265-71.
32. Sherlock M, Toogood AA, Steeds R. Dopamine agonist therapy for hyperproactinaemia and cardiac valve dysfunction; a lot done but much more to do. Heart 2009;95:522-3.
33. Gu H, Luck S, Carroll P, Powrie J, Chambers J. Cardiac valve disease and lowdose dopamine agonist therapy: an artifact of reporting bias? Clin Endocrinol 2011; 74:608-10.
34. Carlson RG, Mayfield WR, Norman S, Alexander JA. Radiations-associated valvular disease. Chest 1991;99:538-45.
35. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echo 2010;11:223-44.
36. Lancellotti P, Tribouilloy C, Hagendorff A, Agricola E, Popescu BA, Christophe Tribouilloy et al. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echo 2010;11:307-32.
37. Baumgartner H, Hung J, Bermejo J, Chambers J, Evangelista A, Griffin BP et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echo 2009;10:1-25.
38. Baumgartner H, Hung J, Bermejo J, Chambers J, Edvardsen T, Goldstein S et al. Focus update on the echocardiographic assessment of aortic valve stenosis: EACVI/ASE recommendations for clinical practice (in press).
39. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
40. Chikwe J, Adams DH, Su KN, Anyanwu AC, Lin HM, Goldstone AB et al. Can three-dimensional echocardiography accurately predict complexity of mitral valve repair? Eur J Cardiothorac Surg 2012;41:518-24.
41. Zamorano J, Cordeiro P, Sugeng L, de Isla LP, Weinert L, Macaya C et al. Realtime three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation. J Am Coll Cardiol 2004;43:2091-6.
42. Zamorano J, de Isla LP, Sugeng L, Cordeiro P, Rodrigo JL, Almeria C et al. Noninvasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J 2004;25:2086-91.
43. Gutierrez-Chico JL, Zamorano JL, Prieto-Moriche E, Hernández-Antolín RA, Bravo-Amaro M, de Isla LP et al. Real-time three-dimensional echocardiography in aortic stenosis: a novel, simple, and reliable method to improve accuracy in area calculation. Eur Heart J 2008;29:1296-306.
44. Monin J-L, Quere J-P, Moncho M, Petit H, Baleynaud S, Chauvel C et al. Low-gradient aortic stenosis. Operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108:319-24.
45. Kamperidis V, van Rosendael PJ, Katsanos S van der Kley F, Regeer M, Al Amri I et al. Low gradient severe aortic stenosis with preserved ejection fraction: reclassification of severity by fusion of Doppler and computed tomographic data. Eur Heart J 2015;36:2087-96.
46. Garbi M, Chambers J, Vannan MA, Lancellotti P. Valve stress echocardiography: a practical guide for referral, procedure, reporting and clinical implementation of results. On behalf of the HAVEC group. JACC Imaging 2015;8:724-36.
47. Magne J, Lancellotti P, Pierard LA. Exercise-induced changes in degenerative mitral regurgitation. JACC 2010;56:300-9.
48. Myerson SG. Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:7.
49. Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-57.
50. Messika-Zeitoun D, Bielak LF, Peyser PA, Sheedy PF, Turner ST, Nkomo VT et al. Aortic valve calcification: determinants and progression in the population. Arterioscler Thromb Vasc Biol 2007;27:642-8.
51. Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarwal SR et al. Impact of aortic valve calcification, as measured by MDCT on survival in patients with aortic stenosis. Results of an international registry study. J Am Coll Cardiol 2014;64:1202-13.
52. Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM et al. Aortic regurgitation quantification using cardiovascular magnetic resonance. Association with clinical outcome. Circulation 2012;126:1452-6.
53. Myerson SG, d'Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM et al. Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantitation. Circulation 2016;133:2287-96.
54. Weidemann F, Herrmann S, Stö rk S, Niemann M, Frantz S, Lange V et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120:577-84.
55. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G et al. Mid-wall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-9.
56. Shah ASV, Chin CW, Vassiliou V, Cowell SJ, Doris M, Kwok TC et al. Left ventricular hypertrophy with strain and aortic stenosis. Circulation 2014; 130:1607-16.
57. de Marvao A, Dawes TJW, Shi W, Minas C, Keenan NG, Diamond T et al. Population-based studies of myocardial hypertrophy: high resolution cardiovascular magnetic resonance atlases improve statistical power. J Cardiovasc Magn Reson 2014;16:16. http://jcmr-online.com/content/16/1/16.
58. Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 2014;35:2873-926.
59. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S et al. Natural history of very severe aortic stenosis. Circulation 2010;121:151-6.
60. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 2014;63:e57-185.
61. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M et al. Predictors of outcome in severe asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7.
62. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-83.
63. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238-44.
64. Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2001;122:919-28.
65. Marechaux S, Ennezat PV, Le Jemtel TH, Polge AS, de Groote P, Asseman P et al. Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study. Echocardiography 2007; 24: 955-9.
66. Marechaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010;31:1390-7.
67. Lancellotti P, Karsera D, Tumminello G, Lebois F, Pierard LA. Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur J Echocard 2008;9:338-43.
68. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005;112:I-377-82.
69. Thorne S. Pregnancy and native heart valve disease. Heart 2016; doi:10.1136/heartjnl-2014-306729.
70. Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart J-M et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:3147-97.
71. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H et al. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205.
72. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989;133:545-50.
73. Cosmi JE, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ESl. The risk of development of aortic stenosis in patients with 'benign' aortic valve thickening. Arch Int Med 2002;162:2345-7.
74. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol 1999;83:897-902.
75. Lebowitz NE, Bella JN, Roman MJ, Liu JE, Fishman DP, Paranicas M et al. Prevalance and correlates of aortic regurgitation in American Indians: the strong heart study. J Am Coll Cardiol 2000;36:461-7.
76. Vaturi M, Porter A, Adler Y, Shapira Y, Sahar G, Vidne B et al. The natural history of aortic valve disease after mitral valve surgery. J Am Coll Cardiol 1999;33:2003-8.
77. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT et al. Outcomes in adults with bicuspid aortic valves JAMA 2008;300:1317-25.
78. Michelena HI, Desjardins VA, Avierinos J-F, Russo A, Nkomo VT, Sundt TM et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community Circulation 2008;117;2776-84.
79. Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
80. Sutton M St J, Weyman AE. Mitral valve prolapse prevalence and complications. Circulation 2002;106:1305-7.
81. Levy D, Savage D. Prevalence and clinical features of mitral valve prolapsed. Am Heart J 1987;113:1281-90.
82. Avierinos J-F, Gersh BJ, Melton LJ, Bailey KR, Shub C, Nishimura RA et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002;106:1355-61.
83. Thorne SA, MacGregor AE, Nelson Piercy C. Risk of contraception and pregnancy in heart disease. Heart 2006;92:1520-5.
84. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6.
85. McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG 2009;116:1585-92.
86. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. JACC 2010;55:1509-44.
87. Rajani R, Hancock J, Chambers J. Imaging: the art of TAVI. Heart 2012;98 (Suppl 4):iv14-22
88. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. SCCT Expert consensus document on CCTA pre TAVI. J Cardiovasc Comput Tomogr 2012;6:366-80.
89. Van Dyck MJ, Watremez C, Boodwhani M, Vanoverschelde J-L, El Khoury G. Transesophageal echocardiographic evaluation during aortic valve repair surgery. Anesthesia Analg 2010;111:59-70.
90. Tsang W, Lang RM. Three-dimensional echocardiography is essential for intraoperative assessment of mitral regurgitation. Circulation. 2013;128:643-52.
91. Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R et al. Recommendations for the Imaging assessment of prosthetic heart valves. A report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography. Eur Heart J CVI 2016;17:589-590. doi:10.1093/ehjci/jew025.
92. Grunkemeier GL, Li H-H, Naftel DC. Long-term performance of heart valve prostheses Curr Prob Cardiol 2000;25:74-154.
93. Rahimtoola SH. Choice of prosthetic heart valve in adults. J Am Coll Cardiol 2010;55:2413-26.
94. Flameng W, Herregods M-C, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves Circulation 2010;121:2123-9.
95. Bourgignon T, Bouquiaux-Stablo A-L, Candolfi P, Loardi C, May M-A, El-Khoury R et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg 2015;99:831-7.
96. David T, Armstrong S, Maganti M. Hancock II Bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg 2010; 90:775-81.
97. Lee AP-W, Acker M, Kubo SH, Bolling SF, Park SW, Bruce CJ et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy. Circulation 2009;119:2606-14.
98. David TE, Ivanov J, Armstrong S. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg 2003;125:1143-52.